To validate whether the RhoJ-PAK signaling network influenced the growth of BRAF mutant tumors, we determined whether PAK inhibitors could block the growth of BRAF mutant autochthonous mouse melanomas during early phases of development. This evidence concerns the gene RHOJ and melanoma.